Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2022, 4(4); doi: 10.25236/FMSR.2022.040407.

Research progress of antitumor peptides

Author(s)

Congying Zhang

Corresponding Author:
Congying Zhang
Affiliation(s)

Basic Medicine College, Chifeng University, Chifeng, China

Abstract

In recent years, with the progress of medical research and the continuous emergence of new antitumor drugs, they have antitumor activity peptides have attracted extensive attention in the field of antitumor drug research and development because they are not easy to produce drug resistance, wide sources, high bioavailability in vivo, good specificity, easy synthesis and low synthesis cost. In this paper, the peptides with antitumor activity from various sources are sorted and analyzed, in order to improve the reference for the in-depth research of antitumor peptides and the development of new drugs.

Keywords

peptide, cancer,antitumor, activities, treatment

Cite This Paper

Congying Zhang. Research progress of antitumor peptides. Frontiers in Medical Science Research (2022) Vol. 4, Issue 4: 44-47. https://doi.org/10.25236/FMSR.2022.040407.

References

[1] Albericio F, Kruger HG. The rapeutic peptides. Future Medicinal Chemistry. 2012, 4(12) :1527-1531.

[2] Roderich D S , Andi M .Nonribosomal Peptide Synthesis-Principles and Prospects. Angew Chem Int Ed Engl. 2017 Mar 27;56(14):3770-3821.

[3] Vlieghe P, Lisowski V, MartinezJ, etal. Synthetic the rapeutic peptides: science and market. Drug Discov Today.2010,15(1–2):40–56.

[4] Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev .2003,55(1):27–55.

[5] Hoda M , Zahra M, Maryam Y, et al. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria. Microb Drug Resist. 2018;24(6):747-767.

[6] Holohan C, Van Schaeybroeck S, Longley DB, et al. Cancer drug resistance: anevolving paradigm. Nature Reviews Cancer.2013,13(10):714–26.

[7] R.J. Boohaker, M.W. Lee, P. Vishnubhotla, et al. Bentham Science Publishers The Use of Therapeutic Peptides to Target and to Kill Cancer Cells.Current Medicinal Chemistry.2012, 19:3794-3804.

[8] Kalyanaraman B., Joseph J., Kalivendi S., Wang, S., et al. Doxorubicin-induced apoptosis: implications in cardiot oxicity. Mol.  Cell  Biochem.  2002, 119-124. 

[9] Naumov G N., Townson J. L., MacDonald I. C., Wilson, et al. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res. Treat. 2003, 82, 199-206.

[10] Bray F, Ferlay J, SoerjomataramI, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394424.

[11] Zhang S, Sun K, Zheng R, et al. Cancer incidence and mortality in China 2015. J Natl Cancer Center 2020. Br J Cancer.2014, 111:1014–1020.

[12] WANG C C , LIU M, CHENG L Y, et al. A novel polypeptide from Meretrix meretrix Linnaeus inhibits the growth of human lung adenocarcinoma. Exp Biol Med (Maywood), 2012, 237(4): 442-450. 

[13] Islam Rady , Imtiaz A Siddiqui , Mohamad Rady , Hasan Mukhtar. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer letter. 2017,402:16-31.

[14] Wang H, Wei J, Wu N, et al. Mere15,a novel polypeptide from meretrix, inhibits adhesion, migration and invasion of human lung cancer A549 cells via down-regulating MMPs [J] Pharmaceutical Biology,2013,51( 2) : 145-151.

[15] Ying Song , Jian-Gang Wang, Rui-Fang Li, et al. Gecko crude peptides induce apoptosis in human liver carcinoma cells in vitro and exert antitumor activity in a mouse ascites H22 xenograft model. J Biomed Biotechnol. 2012; 743573.

[16] Hilary J, John E, et al. Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation. Cancer Chemotherapy Pharmacol.1997,39:223–226

[17] Ruoli Bai, George R, et al. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal: Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. Biochemical Pharmacology.1990,39(12): 1941-1949.

[18] AmmarAlmaaytahaQosayAlbalasb. Scorpion venom peptides with no disulfide bridges: A review.Peptides. Peptides. 2014,51: 35-45.

[19] Kevin M. Gardinier,James W. Leahy. Enantio specific Total Synthesis of the Potent Antitumor  Macrolides Cryptophycins 1 and 8. J. Org. Chem. 1997, 62, 21, 7098–7099.

[20] Gao C, Sun R, XieY R, et al. The soy-derived peptide Vglycin inhibits the growth of colon cancer cells in vitro and in vivo . Exp Biol Med (Maywood), 2017, 242(10): 1034-1043. 

[21] Mcconnell E J, Devapatla B. cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein. Oncotarget,2015,6(7):4649-62.

[22] Chunhua Wang , Dongmei Lin , Quan Chen, et al. Polysaccharide peptide isolated from grass-cultured Ganoderma lucidum induces anti-proliferative and pro-apoptotic effects in the human U251 glioma cell line. Oncol Lett. 2018 ,15(4):4330-4336.

[23] Ruoslahti E. Vascular zip codes in angiogenesis and metastasis [J]. Biochem Soc Trans, 2004, 32: 397-402.

[24] Qin H, Lerman B, Sakamaki I, et al. Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice [J]. Nat Med, 2014, 20: 676-681.

[25] Rodrigo Q,  Bluma F,  Salomao F, et al. Initial studies of radiolabeling and biodistribution of peptide p160 analog with technetium-99m.Journal of Nuclear Medicine,2008 ,5(49) .

[26] AK Singh, R Singh, F Naz, Structure Based Design and Synthesis of Peptide Inhibitor of Human LOX-12:In Vitro and In Vivo Analysis of a Novel Therapeutic Agent for Breast Cancer. PloS one, 2012,7(2).

[27] Sinthuvanich,C.,Veiga,A.S.,Gupta,K., et al. Anticancer β-hairpin peptides:Membrane-induced folding triggers activity.J.Am.Chem.Soc,2012,134:6210–6217.

[28] KN Kirschner, KW lexa, et al. computational design and experimental discovery of an antiestrogenic peptide derived from α-fetoprotein. C.J.AM.CHEM.SOC.2007,129,6263-6268.